8-KOther EventsExhibits & Filings

SYNOPSYS INC 8-K Report, Corporate Update (Sep 1, 2022)

Filed September 1, 2022For Securities:SNPS

Summary

Synopsys, Inc. (SNPS) announced on September 1, 2022, that its Board of Directors has authorized a new stock repurchase program valued at up to $1.5 billion. This action replenishes the company's existing buyback program and provides further flexibility for returning capital to shareholders. The authorization allows Synopsys to purchase its common stock in the open market or through private transactions, subject to market conditions and other factors. While the new authorization signals management's confidence in the company's financial position and future prospects, investors should note that the program is discretionary. Synopsys' leadership, including the CEO and CFO, retains the ability to suspend or terminate the program at any time. This flexibility allows the company to manage its capital allocation effectively while remaining adaptable to evolving market dynamics.

Key Highlights

  • 1Synopsys Inc. announced a new stock repurchase program authorization of up to $1.5 billion.
  • 2The new authorization replenishes the company's existing stock repurchase program.
  • 3The program allows for repurchases of Synopsys common stock.
  • 4Repurchases may occur through open market or private transactions.
  • 5The program is subject to market conditions and management discretion.
  • 6Synopsys' CEO, CFO, or Board can suspend or terminate the program at any time.
  • 7This action indicates management's confidence in the company's financial health and stock valuation.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce that Synopsys Inc.'s Board of Directors has authorized a new stock repurchase program of up to $1.5 billion, replenishing its existing program.

No, the authorization is not an obligation. Synopsys is authorized, but not obligated, to purchase up to $1.5 billion of its common stock. The company can choose when and how much to repurchase, if at all.

It means that the previous stock repurchase authorization had either been fully utilized or was nearing its limit, and this new authorization provides fresh capital for future buybacks, effectively extending or replacing the prior program.

Synopsys' Chief Executive Officer, Chief Financial Officer, or Board of Directors can suspend or terminate the program at any time at their sole discretion, without prior notice. This allows the company to adapt to changing business conditions or capital needs.